Related Experiment Videos

Expression of drs mRNA in human lung adenocarcinomas

Misuzu Shimakage1, Koji Takami, Ken Kodama

  • 1Clinical Research Institute, Osaka National Hospital, Japan.

Human Pathology
|August 2, 2002
PubMed

Insights

The drs gene, a cancer suppressor, is significantly reduced in poorly differentiated lung adenocarcinomas. This down-regulation correlates with tumor progression and poor differentiation, suggesting drs

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Expression

Background:

  • The drs gene was identified as a suppressor of v-src transformation.
  • Reduced drs mRNA expression is observed in various human cancer cell lines.
  • Drs cDNA introduction suppresses anchorage-independent growth in cancer cells.

Purpose of the Study:

  • To investigate the correlation between drs mRNA down-regulation and malignant tumor formation in human lung adenocarcinoma tissues.
  • To examine drs mRNA expression levels in different grades of lung adenocarcinoma differentiation.

Main Methods:

  • In situ mRNA hybridization was used to analyze drs mRNA expression in lung adenocarcinoma tissues.
  • Analysis included well-differentiated, moderately differentiated, and poorly differentiated tissues.
  • Genomic analysis for drs gene deletion or rearrangement was performed.

Main Results:

  • Drs mRNA expression was markedly reduced in all 5 poorly differentiated lung adenocarcinomas.
  • Drs mRNA was significantly expressed in normal lung tissues and some well- and moderately-differentiated adenocarcinomas.
  • No gross deletion or rearrangement of the drs genome was detected.

Conclusions:

  • Down-regulation of drs mRNA is strongly correlated with poor differentiation in lung adenocarcinoma.
  • Reduced drs mRNA expression is linked to the progression of lung adenocarcinoma.
  • Drs gene expression may serve as a biomarker for lung adenocarcinoma progression.

Related Concept Videos